Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1981 Feb;71(2):138–144. doi: 10.2105/ajph.71.2.138

The risk of hip fracture in postmenopausal females with or without estrogen drug exposure.

R E Johnson, E E Specht
PMCID: PMC1619634  PMID: 7457682

Abstract

This study estimated the risk of hip fracture among postmenopausal females with and without estrogen drug exposure. The Kaiser-Permanente Medical Care Program in Portland, Oregon served as the setting and medical records the source of data. A retrospective case-control method that matched each female member hospitalized with a hip fracture (N = 168) between 1965-1975 with two control female members hospitalized for reasons other than a hip fracture was used. The estrogen exposure rate of cases was 29.2 per cent and of controls 36.0 per cent. The risk of hip fracture was reduced with postmenopausal and prefracture estrogen exposure (RML = 0.72, 95 per cent CL: 0.48-1.09). However, the number of cases was sufficient only to detect a reduction in risk of about 50 per cent or greater. A possible protective effect from estrogens was also suggested with oral estrogen exposure and with longer lengths of estrogen exposure.

Full text

PDF
138

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitken J. M., Hart D. M., Lindsay R. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J. 1973 Sep 8;3(5879):515–518. doi: 10.1136/bmj.3.5879.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alhava E. M. Diseases contributing to fragility of bone in patients with hip fractures. Ann Clin Res. 1974 Aug;6(4):246–252. [PubMed] [Google Scholar]
  3. Alhava E. M., Karjalainen P. Mineral content and density of the forearm bones measured by Am-241 gamma ray attenuation method in 80 patients with osteoporotic hip fractures. Ann Clin Res. 1973 Aug;5(4):244–247. [PubMed] [Google Scholar]
  4. Antunes C. M., Strolley P. D., Rosenshein N. B., Davies J. L., Tonascia J. A., Brown C., Burnett L., Rutledge A., Pokempner M., Garcia R. Endometrial cancer and estrogen use. Report of a large case-control study. N Engl J Med. 1979 Jan 4;300(1):9–13. doi: 10.1056/NEJM197901043000103. [DOI] [PubMed] [Google Scholar]
  5. Barnes R., Brown J. T., Garden R. S., Nicoll E. A. Subcapital fractures of the femur. A prospective review. J Bone Joint Surg Br. 1976 Feb;58(1):2–24. doi: 10.1302/0301-620X.58B1.1270491. [DOI] [PubMed] [Google Scholar]
  6. Beals R. K. Survival following hip fracture. Long follow-up of 607 patients. J Chronic Dis. 1972 Apr;25(4):235–244. doi: 10.1016/0021-9681(72)90134-8. [DOI] [PubMed] [Google Scholar]
  7. Davis M. E., Lanzl L. H., Strandjord N. M. Estrogens and the aging process. The detection, prevention, and retardation of osteoporosis. JAMA. 1966 Apr 18;196(3):219–224. [PubMed] [Google Scholar]
  8. HENNEMAN P. H., WALLACH S. A review of the prolonged use of estrogens and androgens in postmenopausal and senile osteoporosis. AMA Arch Intern Med. 1957 Nov;100(5):715–723. doi: 10.1001/archinte.1957.00260110031005. [DOI] [PubMed] [Google Scholar]
  9. Horsman A., Gallagher J. C., Simpson M., Nordin B. E. Prospective trial of oestrogen and calcium in postmenopausal women. Br Med J. 1977 Sep 24;2(6090):789–792. doi: 10.1136/bmj.2.6090.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hutchinson T. A., Polansky S. M., Feinstein A. R. Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study. Lancet. 1979 Oct 6;2(8145):705–709. doi: 10.1016/s0140-6736(79)90640-8. [DOI] [PubMed] [Google Scholar]
  11. Iskrant A. P., Smith R. W., Jr Osteoporosis in women 45 years and over related to subsequent fractures. Public Health Rep. 1969 Jan;84(1):33–38. [PMC free article] [PubMed] [Google Scholar]
  12. Kohn P., Zekert F., Vormittag E., Grabner H. Risks of operation in patients over 80. Geriatrics. 1973 Nov;28(11):100–105. [PubMed] [Google Scholar]
  13. Lindsay R., Hart D. M., Aitken J. M., MacDonald E. B., Anderson J. B., Clarke A. C. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet. 1976 May 15;1(7968):1038–1041. doi: 10.1016/s0140-6736(76)92217-0. [DOI] [PubMed] [Google Scholar]
  14. Lindsay R., Hart D. M., MacLean A., Clark A. C., Kraszewski A., Garwood J. Bone response to termination of oestrogen treatment. Lancet. 1978 Jun 24;1(8078):1325–1327. doi: 10.1016/s0140-6736(78)92402-9. [DOI] [PubMed] [Google Scholar]
  15. Mack T. M., Pike M. C., Henderson B. E., Pfeffer R. I., Gerkins V. R., Arthur M., Brown S. E. Estrogens and endometrial cancer in a retirement community. N Engl J Med. 1976 Jun 3;294(23):1262–1267. doi: 10.1056/NEJM197606032942304. [DOI] [PubMed] [Google Scholar]
  16. Meema H. E., Meema S. Prevention of postmenopausal osteoporosis by hormone treatment of the menopause. Can Med Assoc J. 1968 Aug 10;99(6):248–251. [PMC free article] [PubMed] [Google Scholar]
  17. Meema S., Bunker M. L., Meema H. E. Preventive effect of estrogen on postmenopausal bone loss. Arch Intern Med. 1975 Nov;135(11):1436–1440. [PubMed] [Google Scholar]
  18. Miettinen O. S. Individual matching with multiple controls in the case of all-or-none responses. Biometrics. 1969 Jun;25(2):339–355. [PubMed] [Google Scholar]
  19. Smith D. C., Prentice R., Thompson D. J., Herrmann W. L. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med. 1975 Dec 4;293(23):1164–1167. doi: 10.1056/NEJM197512042932302. [DOI] [PubMed] [Google Scholar]
  20. Stadel B. V., Weiss N. Characteristics of menopausal women: a survey of King and Pierce counties in Washington, 1973-2974. Am J Epidemiol. 1975 Sep;102(3):209–216. doi: 10.1093/oxfordjournals.aje.a112149. [DOI] [PubMed] [Google Scholar]
  21. Sweet M. B., Mendelow A., Kotler M. N., Graham W. D. Fractured neck of femur. Associated morbidity and mortality. S Afr J Surg. 1967 Jan-Mar;5(1):57–64. [PubMed] [Google Scholar]
  22. Wylie C. M. Hospitalization for fractures and bone loss in adults. Why do we regard these phenomena as dull? Public Health Rep. 1977 Jan-Feb;92(1):33–38. [PMC free article] [PubMed] [Google Scholar]
  23. Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975 Dec 4;293(23):1167–1170. doi: 10.1056/NEJM197512042932303. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES